Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.5.4 was added to the page history. The previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s interface revision/version has been updated from **v3.5.2** to **v3.5.3**. No study record content or clinical information appears to change with this revision marker.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded a new revision entry v3.5.2 to the record history and removed the v3.5.0 entry.SummaryDifference0.1%

- Check66 days agoChange DetectedA new site revision entry appears: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor page update with no visible changes to study information.SummaryDifference0.1%

- Check102 days agoChange DetectedRevision: v3.4.2 has been added to the history. The funding-status notice and the older Revision: v3.4.1 entry were removed.SummaryDifference0.5%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.